Please get vaccinated

First time at AMP. Excellent talks and debates. Very educational live cases! Would highly recommend to CLI operators AMP the CLTI Meeting Fadi Saab Mohammad (Mac) Ansari, MD CLI Global Society

Interpretation of Pulmonary Angiography can be challenging due to the # of vessels, anatomical variance and vessel overlap. Vikas Aggarwal and I put together a talk on this topic w/ help of SCAI scai.org/how-interpret-…. #ACCFIT #CardioTwitter Here is a summary:

This is why you don't just "open the side" Gregor Leibundgut Carlo Tumscitz Stefan Harb Evandro Martins F. MD Prof.N John Camm marc madalin PCRonline 🫀 Andrew SP Sharp MIЯVΛƬ #IC ༄ ｡° Gabor G Toth

A moment to remember, when we were able to snare, latch on, and electrocautarize a large aortic fibroelastoma which came out in one piece!

AKU Class of 2011, 10 year (slightly delayed) reunion. The best years with the best people around. 011 Full speed ahead! 💪🏻 Aga Khan University Adil Haider Dr Farhat Abbas, T.I,S.I AKU Alumni Association of North America

It has been an honor contributing to the training of these two star IC fellows. Onwards and upwards! ا Prasanna Sengodan Neeraj Shah ECU Cardiology

Learning complex PCI from the brilliant Saroj Neupane Saroj Neupane Prasanna Sengodan

Just published in Circulation CI: the latest evidence in the treatment of high-risk PE 🔥#FLAME is the largest prospective study of interventional treatment in #highriskPE. This #datamatters 🧵 ahajournals.org/doi/10.1161/CI… #MitchSilver C. Michael Gibson MD Jay Giri #SameerKhandar

Cause of no-reflow not always in coronaries. Pay attention to guide position and engagement. Guide cath-induced acute AI. Hemodynamics compromise, no reflow. Improved by guide repositioning.

Just out today: First drug-coated balloon for the coronary circulation now approved in the US, for in-stent restenosis. prnewswire.com/news-releases/…

Catheter based therapies in intermediate or high risk PE— associated with lower mortality and readmission. RCTs eagerly awaited. Glenn Fishman NYU Langone Health Jay Giri Sahil A. Parikh, MD Catalin Toma, MD Sanjum S. Sethi MD, MPH Andrew SP Sharp The PERT Consortium®

I can’t remember a conference with so many positive studies for interventional cardiology #ACC2024

Recent advances in Cardiology. (For residents, fellows and professionals in Cardiology) #CardioTwitter #cardioEd All the trials presented at #ACC2024

Complete revascularization is now "a must" in ACS, but the optimal timing remains a matter of controversy: immediate? Staged in-hospital? Staged within 45 days? Staged when you want? This prespecified analysis of the randomized BIOVASC trial suggests that immediate complete

The Sideclose technique for #Impella access site bleeding new in MyJSCAI. Stop the bleeding, keep the Impella! @jason_wollmuth #MCS doi.org/10.1016/j.jsca…

What do PE thrombectomy docs do for post lytic cases? How long do you wait to assess lytic success or failure? This is an example of thrombectomy performed 6-8 hours post full dose lytics with worsening shock.

Today we celebrated the success of our PERT program with our dedicated and exceptional team. The goal remains to select appropriate cases to improve outcomes in our patients with venous thromboembolism ECU Health Prasanna Sengodan Paul Mahoney